April 19, 2021, 18:47

CDC Panel Recommends Use of J&J Coronavirus Vaccine

CDC Panel Recommends Use of J&J Coronavirus Vaccine

Earlier the US Food and Drug Administration (FDA) issued an emergency use authorization for the third COVID-19 vaccine, developed by Belgium-headquartered pharmaceutical company Janssen. The drug was proved to be effective to approximately 77 percent. At the same time, Johnson & Johnson jabs were said to cause a number of severe side effects.

An advisory panel with the US Centers for Disease Control and Prevention (CDC) voted on Sunday to approve the use of the Johnson & Johnson vaccine against the coronavirus for adults over 18.

Earlier on Saturday the US Food and Drug Administration (FDA) approved the coronavirus vaccine developed by Johnson & Johnson for emergency in the country.

According to the regulator, the vaccine is effective in 66–67% of cases in preventing a disease of “moderate” severity and in 77–85% of cases in preventing “severe” cases.

This is the third vaccine approved for use in the US. In December 2020, the regulator approved a vaccine developed in partnership between American company Pfizer and German company BioNTech, along with another vaccine produced by Moderna.

Earlier the US president has announced that over 50 million American citizens have already been imminized. According to him the vaccination in the US is going ahead of schedule as he previously promised to vaccinate 100 million Americans during the first 100 days of his presidency.

According to Johns Hopkins University data tracking, the US has recorded 28.6 million cases of COVID-19 infection along with 513,000 deaths. For both indicators, the country ranks first in the world.

Sourse: sputniknews.com

Related posts

Leave a Reply

Your email address will not be published. Required fields are marked *

We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies. You can find a detailed description in our Privacy Policy.